These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23444930)
1. Landmarks in hormonal therapy for prostate cancer. Tombal B; Crawford ED BJU Int; 2013 Mar; 111(3):E12-3. PubMed ID: 23444930 [No Abstract] [Full Text] [Related]
2. Reply: Landmarks in hormonal therapy for prostate cancer. Hammerer P; Madersbacher S BJU Int; 2013 Mar; 111(3):E13-5. PubMed ID: 23444931 [No Abstract] [Full Text] [Related]
3. Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction. Gomella LG BJU Int; 2007 Jan; 99 Suppl 1():1. PubMed ID: 17229158 [No Abstract] [Full Text] [Related]
5. Primary androgen deprivation therapy in men with prostate cancer. Laufman L JAMA; 2009 Jan; 301(1):35; author reply 35. PubMed ID: 19126809 [No Abstract] [Full Text] [Related]
6. Role of radiation and androgen deprivation therapy for advanced prostate cancer. Jani AB; Rossi PJ Curr Probl Cancer; 2015; 39(1):41-7. PubMed ID: 25554467 [No Abstract] [Full Text] [Related]
7. Hormone therapy for prostate cancer: what have we done with Charles Huggins' legacy? Tombal B Eur Urol; 2012 Jan; 61(1):26-8. PubMed ID: 21940097 [No Abstract] [Full Text] [Related]
16. Hormonal therapy options for prostate-specific antigen-only recurrence of prostate cancer after previous local therapy. Moul JW; Zlotta AR BJU Int; 2005 Feb; 95(3):285-90. PubMed ID: 15679779 [No Abstract] [Full Text] [Related]
17. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist. Boudreaux KJ; Chang SS BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172 [No Abstract] [Full Text] [Related]
18. Words of Wisdom. Re: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer. Isbarn H Eur Urol; 2016 Feb; 69(2):372-3. PubMed ID: 26758519 [No Abstract] [Full Text] [Related]
19. Management of the hormone sensitivity of prostate cancer: where are we now? Alcaraz A Eur Urol; 2008 Aug; 54(2):247-50; discussion 250-1. PubMed ID: 18343562 [No Abstract] [Full Text] [Related]
20. Secondary hormonal therapy for prostate cancer: what lies on the horizon? Sharifi N; Dahut WL; Figg WD BJU Int; 2008 Feb; 101(3):271-4. PubMed ID: 17922868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]